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The aim of this study was to investigate the iron concentrations in serum and carotid plaque in patients with different 
morphology of carotid atherosclerotic plaque and compared with other metal ions. Carotid endarterectomy due to 
the significant atherosclerotic stenosis was performed in 91 patients. Control group consisted of 27 patients, without 
carotid atherosclerosis. Atherosclerotic plaques were divided into four morphological groups, according to ultrasonic 
and intraoperative characteristics. Iron, copper and zinc concentration in plaque, carotid artery and serum were 
measured by spectrophotometry. Serum iron concentrations were higher in patients with hemorrhagic plaques in 
comparison to the control group (4.7 μmol/l ± 1.2 vs. 2.1 μmol/l ± 0.8, p < 0.05). Iron concentrations were higher in 
patients with hemorrhagic plaques in comparison to fibrolipid plaques (72.1 ± 14.3 μg/g vs. 39.3 ± 22.9 μg/g; 
p < 0.05). Negative significant correlation was found for zinc in serum and plaque iron concentration in patients 
(p < 0.05). We also demonstrated positive significant correlation for copper and iron in serum (p < 0.05). The data 
obtained in the current study are consistent with the hypothesis that high iron levels may contribute to atherosclerosis 
and its complications as factors in a multifactorial disease. 
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Over the last 30 years, several studies in animals and humans assessed the effect of increased 
body iron levels on atherosclerosis, yielding conflicting results.
Iron is a key element in many biochemical processes and shortage of iron causes damage 
to cells and organs. On the other hand, excess iron could be harmful because it is able to 
catalyse the formation of highly reactive oxygen and hydrogen radicals when present in the 
unbound state. Transition metal ions, established catalysts of protein, lipid and DNA 
oxidation, are present at elevated levels in human atherosclerotic plaques, and in some animal 
models, consistent with the hypothesis that metal ions contribute to both plaque formation 
and its destabilization (19, 21, 23), though the role of metal ions remains controversial 
(16, 29).
Epidemiological studies have reported an increased incidence of cardiovascular disease 
(CVD) in subjects with overt iron overload (7, 8, 19). Recent studies on cardiovascular 
evaluation and outcome in high- versus low-frequency blood donors have demonstrated 
improvements in surrogate markers of vascular health such as decreased oxidative stress, and 
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enhanced vascular reactivity (3). Several population studies have reported a direct association 
between increased iron intake, body iron stores, and CVD risk; in particular, elevated intake 
of heme iron is associated with increased CVD events, and increased total body iron stores 
with myocardial infarction (MI) (24). 
Although convincing evidence has been previously provided for elevated levels of iron 
and copper ions in advanced human lesions (21, 23), and for a correlation between metal ion 
levels and the extent of protein oxidation (23), these studies have not examined specific 
populations. Current evidence and pathophysiological considerations suggest that the 
increased intraplaque iron deposition may be associated with increased oxidative stress, 
affecting the stability of the carotid plaque (12). Thus, data on the abundance of metal ions 
in atherosclerotic lesions, and its potential correlation with clinical symptoms is lacking. 
A number of studies have reported associations between metals and atherosclerosis, evaluated 
by carotid artery intima-media thickness (IMT) measurement (11).
The present study was aimed at examining the relationship between measures of iron 
status in serum and carotid plaque in patients with different morphology of carotid 
atherosclerotic plaque. We compared the concentrations of iron with concentrations of metal 
ions (zinc, copper) in serum and carotid plaque in patients. 
Patients and Methods
Patients
The study group consisted of 118 subsequent patients (mean age 63 ± 8 yrs; 54.2% males) 
admitted to the Department of Vascular Surgery at Dedinje Cardiovascular Institute for 
carotid surgery. Carotid endarterectomy due to the significant atherosclerotic stenosis and 
symptoms of cerebrovascular insufficiency was performed in 91 patients (mean age 64.2 ± 
6.9 yrs, 62.6% males). Control group consisted of 27 patients (mean age 58.4 ± 9.3 yrs, 
25.9% males) without carotid atherosclerosis which were operated due to the symptomatic 
kinking and coiling of carotid artery. 
All patients underwent neurological, cardiological and vascular surgeon exam, carotid 
artery ultrasound measurements and were treated surgically. Blood samples were drawn from 
all patients before surgery and sera were analyzed for the concentrations of iron, copper 
and zinc.
Tissue samples, atherosclerotic plaques from atherosclerotic patients and normal carotid 
tissue from the control group patients were analyzed for the concentrations of iron, copper 
and zinc. In atherosclerotic subjects, atherosclerotic plaques were divided into four 
morphological groups, that is fibrolipid, hemorrhagic, ulcerated and calcified plaque, 
according to ultrasonic and intraoperative characteristics (4).
The study was approved by the Ethics Committee of the Dedinje Cardiovascular 
Institute. Written consent was obtained from all patients before they entered the study. 
Analytical methods
Copper and zinc concentrations in plaque, carotid artery tissue and serum were estimated by 
means of flame atomic absorption spectrophotometry (AAS) using the Varian AA-5 
instrument and the instrumental conditions recommended by the producer (acetylene/air 
flame, wavelenght: λCu = 324.75 nm, λZn = 213.86 nm; λFe = 248.3 nm).
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Statistical analysis
Data are presented graphically as box-plots, showing the median, minimum and maximum 
value. Differences in quantitative variables were assessed using the Mann–Whitney U test. 
The associations between groups were analyzed by Spearman’s correlation. A p value < 0.05 
was considered statistically significant. Data were analyzed by SPSS version 10 (SPSS Inc, 
Chicago, Illinois, USA).
Results
Our patient cohort exhibited most of the classic atherosclerosis risk factors (Table I). The 
percentage of hypertensive, smoking subjects was higher in patients with carotid plaque than 
in controls (p < 0.05). The presence of diabetes showed statistically significant differences 
between patients and controls (p < 0.05).
Table I. Baseline characteristics of study sample





Age 64.2 ± 6.9 58.4 ± 9.3 p > 0.05
Hypertension (%) 90.1 59.3 p < 0.05
Smokers (%) 67 40.7 p < 0.05
Diabetes (%) 26.4 14.8 p < 0.05
Family history (%) 49.4 55.6 p > 0.05
Carotid artery bruit (%) 90.1 33.3 p < 0.05
Atherosclerotic subjects were divided in four groups according to different morphology 
of analyzed atherosclerotic plaques (4). First (I) group (22; 18.6%) represents patients with 
fibro-lipid atherosclerotic plaque. 
In the second (II) group there were the patients with hemorrhagic plaque (8 patients; 
6.8%), in the third (III) group those with ulcerated plaque (30 patients; 25.4%) and the fourth 
(IV) group consisted of patients with calcified atherosclerotic plaque (30 patients; 25.4%). 
Patients of the control group, without significant atherosclerotic changes in the carotid artery 
constitute the fifth group (27 patients; 22.9%).
Distribution of iron concentrations in plaque, carotid tissue and serum are shown in Figs 
1 and 2, respectively. 
Our study revealed significantly higher average serum iron concentration in patients 
with hemorrhagic plaque (II) compared to patients in the control group (4.7 μg/l ± 1.2 vs. 2.1 
μg/l ± 0.8, p < 0.05). The average values of iron concentrations in different morphology 
atherosclerotic plaques and normal carotid tissue were similar (Fig. 1).
We found significantly higher average iron plaque concentration in patients with 
hemorrhagic plaque (II) in comparison to patients with fibro-lipid (I) plaques (72.1 ± 14.3 
μg/g vs. 39.3 ± 22.9 μg/g; p < 0.05) (Fig. 2). 
We also demonstrated negative significant correlation for iron plaque concentration and 
zinc in serum in atherosclerotic patients (p = 0.042) (Fig. 3).
Positive and significant correlation coefficients were calculated for iron in serum and 
copper in serum in atherosclerotic patients (p = 0.017) (Fig. 4).
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Fig. 1. Average serum iron (Fe) concentration in 
different morphological groups of atherosclerotic 
plaques. Groups of patients: I – with fibro-lipid 
atherosclerotic plaque; II – with hemorrhagic plaque; 
III – with ulcerated atherosclerotic plaque;  
IV – with calcified atherosclerotic plaque.  
*p < 0.05 (statistically significant difference  
between the groups II and control group)
Fig. 2. Average plaque iron (Fe) concentration in 
different morphological groups of atherosclerotic 
plaques. Groups of patients: I – with fibro-lipid 
atherosclerotic plaque; II – with hemorrhagic plaque; 
III – with ulcerated atherosclerotic plaque;  
IV – with calcified atherosclerotic plaque.
*p < 0.05 (statistically significant difference  
between the groups I and II)
Fig. 3. Analysis of the association of iron (Fe)  
in the carotid plaque and zinc (Zn) in serum of the 
patients studied.
p = 0.042; FE(K); plaque iron (Fe) concentration
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Fig. 4. Analysis of iron (Fe) concentrations  
in serum and copper (Cu) in the serum of patients 
with pronounced atherosclerosis.
p = 0.017; FE(S); iron concentrations in serum
Distribution of patients according to gender in relation to the value of iron in carotid 
plaque showed higher values of iron in groups of patients with pronounced atherosclerosis in 
men than women (p < 0.05) (data not showed).
Discussion
This study complements previous studies on the levels of metal ions in advanced human 
atherosclerotic lesions (20, 21, 23). Unlike these previous studies this work has quantified 
these parameters in two sample groups. It was hypothesised that lesions from patients with 
carotid plaques would contain higher levels of metal ions. The data obtained from these 
groups were compared to control subjects without significant atherosclerotic changes in 
carotid artery. Previous studies have reported that advanced atherosclerotic lesions have 
higher metal ion levels than initial lesions or healthy tissue (11, 21, 22).
Site-specific effects on the development of atherosclerosis are well established, with a 
recent review (5) emphasizing the importance of studying the dynamics and location of trace 
metal ions in vivo, in order to assess the significance of these elements in disease development. 
Iron is present in the atherosclerotic plaque at concentrations that appreciably exceed those 
found in healthy arterial tissue (24). This iron is not simply an inert component of the plaque. 
Some of the arterial iron is redox active and the ferritin- and hemosiderin-bound iron 
compartment remains a reservoir of potentially reactive iron within lesions. We have shown 
significantly higher iron plaque concentration in patients with hemorrhagic plaque in 
comparison to patients with fibro-lipid plaques. The findings support the concept that arterial 
plaque iron is a modifiable risk factor for atherogenesis (24). The finding that human 
atherosclerotic plaques contain redox-active iron that could promote free radical formation 
and lipid peroxidation, further suggested a role for iron in atherosclerosis that may be 
eventually responsible for progressive oxidative damage in atherosclerotic lesions. Recent 
studies show that iron may play a key role in plaque vulnerability and contributes to plaque 
hemorrhage (13, 14). Biologically plausible mechanisms for this association have been 
described, however, epidemiological studies on iron status and CVD risk have provided 
conflicting result (9). Extreme conditions of iron deficiency, as well as of iron overload, are 
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associated with modestly increased CVD risk, although with different proposed mechanisms 
(9). The findings support the concept that arterial plaque iron is a modifiable risk factor for 
atherogenesis. Stadler et al. (21) quantified iron in ex vivo carotid lesions and in healthy 
human arteries. They found elevated levels of iron in the intima of lesions compared with 
healthy controls. In a later work (23), iron levels in human atherosclerotic plaque correlated 
positively and strongly with multiple markers of protein oxidation.
Our study revealed significantly higher average serum iron concentration in patients 
with hemorrhagic plaque compared to patients in the control group. The results of several 
human studies strongly suggested a relationship between body iron levels and atherosclerosis. 
According to the epidemiological studies, high systemic iron levels, monitored by serum 
ferritin levels or transferrin saturation, positively correlated with an increased risk of 
myocardial infarction (7, 18). A protective effect of iron depletion that may have multiple 
beneficial consequences is decreased availability of redox-active iron in vivo (25). It has been 
proposed that the amount of free iron available at sites of oxidative or inflammatory injury is 
a function of the stored iron level and that the availability of redox-active iron in vivo 
approaches its minimum in the state of iron depletion. There is significant experimental 
support for this concept (24). In particular, it has been shown that removal of stored iron from 
the body can decrease the amount of iron deposition within atherosclerotic lesions in animal 
studies. Depletion of lesion iron levels in vivo by phlebotomy, systemic iron chelation 
treatment or dietary iron restriction reduces lesion size in these studies and increases plaque 
stability (10, 15, 27). The original formulation of the iron hypothesis did not specify a 
mechanism. There may well be multiple mechanisms by which iron depletion protects against 
atherosclerosis. Paramonov et al. did not register significant difference in serum iron in 
patients with different forms of coronary heart disease and healthy control subjects (17).
Distribution of patients according to gender in relation to the value of iron in carotid 
plaque showed higher values of iron in groups of patients with pronounced atherosclerosis in 
men than women. Wolff et al. examined the correlation of serum ferritin and IMT thickness 
in the general population. Analysis of the results shows a significant positive correlation 
between these parameters only in men. In women ferritin had no predictive value for carotid 
atherosclerosis (28). This suggests that the observed difference between men and women 
may be a result of physiological differences (i.e. menstruation and hormone secretion) that 
affect iron storage.
We also demonstrated negative significant correlation for iron plaque concentration and 
zinc in serum. Studies have reported that low zinc concentration may have an important role 
in the pathogenesis of atherosclerosis (2). Low serum zinc/24-hour urine zinc ratio is 
associated with angiographically severe atherosclerosis. It was observed that low zinc levels 
were associated with patients with cardiovascular diseases (1, 6).
Epidemiological studies have sought to link various measures of iron and copper with 
the incidence of cardiovascular disease, after the suggestion that the development of disease 
is linked to iron stores, with iron-deficiency offering protection (21). These data are equivocal, 
with positive associations detected in some studies but not others. Positive and significant 
correlation coefficients were calculated for iron in serum and copper in serum in our patients. 
Iron and copper can promote oxidative damage to extracellular matrix components (21). 
These elevated levels of metal ions may therefore affect plaque stability and propensity to 
rupture.
Additional studies are needed to better characterize the significance of the various 
concentrations of iron within the plaque and to assess the clinical utility of non-invasive 
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measures of plaque iron in the clinical determination of plaque stability. Despite the large 
number of studies having been published to date, the role of iron in CVD still generates a fair 
amount of debate (26). 
However, the impact of iron on atherosclerosis is still debated. Comprehensive 
understanding of the role of iron and other metal ions on atherogenesis may lead to the 
development of improved diagnosis and treatment of atherosclerosis. Future studies are 
required to clearly address whether iron overload is a risk factor for atherosclerosis and what 
iron source – systemic or tissue iron – affects mainly the atherosclerotic process. Future 
studies are needed to clarify the real effect of iron on CVD.
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